News Release

ViaVid Interviews Vice President, Shareholder Communications

Date: September 20, 2000

CDNX Trading Symbol: WXI
World Wide Web: http://www.wextech.ca
E-mail: wex@wextech.ca

On Tuesday, September 19th, Mr. Howard Milne, V.P., Shareholder Communications of International Wex Technologies (the "Company"),was interviewed on ViaVid Broadcasting Corporation. Viavid is an OTC Bulletin Board company whose symbol is VVDB. It is a global internet video broadcasting company that offers a network of video services utilizing streaming video technology. ViaVid's business segment, VCB News 1, provides unique coverage of the North American public markets with the ability for viewers to interact live with guests. Conducting the interview for ViaVid's business segment, VBC New 1, was news anchor, Ms. Samantha Sewell.

During the course of the interview, Mr. Milne provided a brief overview of International Wex Technologies Inc., and it's flagship product Tetrodin. Topics such as time-frame for IND filing in Canada, desire to find a strategic alliance partner and preparing for FDA filing were discussed.

This interview may currently be viewed online at http://www.viavid.com/home.asp, and will be archived for future reference at http://www.viavid.com/archive.asp. In order to watch this streaming video footage, viewers will require the Flash Plugin or Windows Media Player. This software is available free from the ViaVid website.

Tetrodin has been developed by the Company primarily as a treatment for the symptoms associated with withdrawal from all opiate addictions such as morphine, opium, heroin and methadone. It is a non-narcotic pharmaceutical that has proven to be safe and effective and functions well in both primary withdrawal treatment and abstinence maintenance (longer term use) of drug addiction. The Company has also begun tests on the usage of Tetrodin as a potent analgesic.

For additional information on Tetrodin(HT), view the IWT website at http://www.wextech.ca or call Howard Milne , V. P. Shareholder Communications, at 604-683-8880 or 1-800-722-7549.

Per: Donna Shum, Corporate Secretary

The Canadian Venture Stock Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this News Release.